Challenges of drug risk communications in the philippines

Drug Safety

Volumn 35, Issue 11, 2012, Pages 995-1004

  Hartigan Go, Kenneth ^a  

^a Asian Institute of Management   (Philippines)

Author keywords

Pharmacovigilance; Risk communication.

Indexed keywords

ASCORBIC ACID; BISACODYL; CHORIONIC GONADOTROPIN; DEXFENFLURAMINE; FENFLURAMINE; FUROSEMIDE; METERGOTAMINE; NICOTINAMIDE; NON PRESCRIPTION DRUG; POTEN CEE; PRESCRIPTION DRUG; TETANUS TOXOID; THYROID HORMONE; UNCLASSIFIED DRUG;

AGE; ARTICLE; DRUG INDUSTRY; DRUG MARKETING; DRUG SURVEILLANCE PROGRAM; HEALTH PRACTITIONER; HUMAN; OFF LABEL DRUG USE; PATIENT CARE; PATIENT SAFETY; PERCEPTION; PHARMACIST; PHARMACY; PHILIPPINES; POVERTY; PRESCRIPTION; PRIORITY JOURNAL; QUALITY CONTROL; READING; RISK BENEFIT ANALYSIS; RISK COMMUNICATION; RISK MANAGEMENT; SELF MEDICATION; SOCIAL MEDIA;

COMMUNICATION; DRUG TOXICITY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOVIGILANCE; PHILIPPINES; PHYSICIAN-PATIENT RELATIONS; RISK; RISK MANAGEMENT; SOCIOECONOMIC FACTORS;

EID: 84867501264     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11635920-000000000-00000     Document Type: Article

References (42)

1. Hugman B. Expecting the worst. 2nd ed. Sweden: Uppsala Monitoring Center, 2010
2. Fischhoff B, Brewer NT, Downs JS, editors. Communicating risks and benefits: an evidence-based user's guide. FDA, US Department of Health and Human Services, 2011
3. Smith RD. Responding to global disease outbreaks: lessons from SARS on role of risk perception, communications and management. Soc Sci Med 2006; 6: 3113-23
4. Steinberg RM. Governance, risk management and compliance. Hoboken (NJ): Wiley & Co., 2011
5. Hugman B. Risk communication. In: Hugman B, editor. Healthcare Communication. Pharmaceutical Press, 2009: 195-206
6. McEwen J. Risk management from an Asian/Pacific Rim regulatory perspective. Drug Saf 2004; 27 (8): 491-7
7. United Nations Development Programme. Human Development Report 2011. Sustainability and equity: a better future for all [online]. Available from URL: http://hdr.undp.org/en/reports/global/hdr2011/[Accessed 2012 Sep 3]
8. National Statistics Office. Functional literacy education mass media survey 2003 [online]. Available from URL: http://census.gov.ph/data/sectordata/ 2003/fl03-lsf01.htm [Accessed 2012 Sep 3]
9. Punongbayan M. Herbal industry files graft raps vs. Cabral [online]. Available from URL: www.philstar.com/article. aspx?articleid=578823 [Accessed 2012 Sep 10]
10. Luci CM. Palace official supports Cabral in fight against herbal trade [online]. Available from URL: www.mb.com. ph/node/260529/palace-official [Accessed 2012 Sep 10]
11. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalization of the elderly. Arch Intern Med 1990; 150 (4): 841-5
12. HcG vaccine for population control [online]. Available from URL: http://www.tetrahedron.org/articles/new-world-order/HcG-Vaccine-for-Pop. -Control.html [Accessed 2012 Sep 3]
13. Deveugele M, Derese A, Vandenbrink-Muinen A, et al. Consultation length in general practice: cross sectional study in 6 European countries. BMJ 2002; 325: 472-4
14. Wooldridge AN, Arato N, Sen A, et al. Truth or fallacy? 3 hour wait for 3 minute with doctor: findings from a private clinic in rural Japan. Asia Pac Fam Med 2010; 9: 11 [online]. Available from URL: http://www.apfmj.com/con tent/9/1/11 [Accessed 2012 Sep 3]
15. Universal Health Care Study Group [online]. Available from URL: http://www.universalhealthcare.ph/[Accessed 2012 Sep 3]
16. Ac-ac M, Calabia RA. IBON Foundation, Inc. Special report: public safety and substandard drugs (1). Government hospitals: a haven for substandard drugs [online]. Available fromURL: http://70.85.145.34/~ibon/news/if/01/sr-01.htm [Accessed 2012 Sep 3]
17. Hofile CF. Medicines that kill [online]. Available from URL: http://archives.newsbreak-knowledge.ph/2002/05/26/medicines-that-kill/[Accessed 2012 Sep 3]
18. Trap B, Hansen EH, Hogerzeil HV. Prescription habits of dispensing and non-dispensing doctors in Zimbabwe. Health Policy Plan 2002; 17 (3): 288-95
19. Baines DL, Tolley KH, Whynes DK. The costs of prescribing in dispensing practices. J Clin Pharm Ther 1996; 21 (5): 343-8
20. James CD, Peabody J, Solon O, et al. An unhealthy publicprivate tension: pharmacy ownership, prescribing, and spending in the philippines. Health Affs 2009; 28 (4): 1022-33
21. Hitt E. Some FDA warnings have minimal effect. Medscape Today. 2012 Feb 14 [online]. Available from URL: http://www.medscape.com/viewarticle/758629
22. Dowden JS. Critical appraisal: court in the act [editorial]. Austral Prescriber 2012; 25 (2): 38-9
23. Macasaet AP. Unilab's summit are plain junkets [online]. Available from URL: http://www.malaya.com.ph/index. php/opinion/7588-unilabs-summit-are-plain- junkets [Accessed 2012 Sep 3]
24. Incidental intelligence: 'FEElipines' [online]. Available from URL: http://archive.malaya.com.ph/2011/February/feb15/bus-incidental.html [Accessed 2012 Sep 3]
25. The Mexico City principles for voluntary codes of business ethics in the biopharmaceutical sector [online]. Available from URL: www.prema.or.th/uploads/ files/news/1100041288-the%20Mexico%20City%20Principles.pdf [Accessed 2012 Sep 10]
26. IFPMA. Ethical promotion of medicines: latest developments and future prospects [online]. Available from URL: http://www.ifpma.org/fileadmin/content/ Events/Pharma-Forums/1-December-2011/Highlights-Ethical-Promotion. pdf [Accessed 2012 Sep 3]
27. Ernst E. Toxic heavy metals and undeclared drugs in Asian herbal medicines. Trends Pharmacol Sci 2002; 23 (3): 136-9
28. Tan M. Side effects. Philippine Daily Inquirer, May 19, 2006 [online]. Available from URL: http://opinion.inquirer.net/inquireropinion/columns/view/ 20060519-2225/Side-effects [Accessed 2012 Sep 3]
29. Larson H, Brocard P, Garnett G. The Indian HPV-vaccine suspension. Lancet 2010; 376: 572-3
30. Bate R, Mooney L, Milligan J, Dangerous substandard medicines: an increasing global problem. American Enterprise Institute for Public Policy Research, No. 6, July 2011 [online]. Available from URL: http://www.aei.org/ files/2011/07/06/HPO-2011-07-No-6-g-new.pdf [Accessed 2012 Sep 3]
31. Dalmacion G, De Ocampo EJ, Amarillo MLE. Comparative bioavailability of three rifampicin preparations. Acta Med Philipp 2006; 40 (2): 28-31
32. The safety of medicines in public health programmes. Geneva: WHO, 2006
33. Bottomly D. Dying to be thin in Singapore [online]. Available from URL: http://news.bbc.co.uk/2/hi/asia-pacific/2036480.stm [Accessed 2012 Sep 3]
34. WHO pharmaceuticals newsletter No. 3 and No. 4. 2002 [online]. Available from URL: http://www.who.int/medi cines/publications/newsletter/en/[Accessed 2012 Sep 3]
35. Lau G, Lo DST, Yao YJ, et al. A fatal case of hepatic failure possibly due to nitrosofenfluramine. Med Sci Law 2004; 44: 252-3
36. Republic of the Philippines, Department of Health, Bureau of Food and Drugs. BFAD advisory no. 99-02. Warning on the use of Bangkok pills. [online]. Available from URL: http://www.fda.gov.ph/Advisory/Pharma/FA%2099-02-9- 24%20Warning%20on%20the%20use%20of%20bangkok% 20pills.pdf [Accessed 2012 Sep 3]
37. Tan G. Bangkok pills and ills. HealthBeat Mag 1999 Jul-Aug; 4 (19): 9-10
38. Republic of the Philippines, Department of Health, Bureau of Food and Drugs. BFAD advisory no. 99-02. Warning on the use of Bangkok pills and other unregistered slimming and fat-reducing drug products [online]. Available from URL: http://www.fda.gov.ph/Advisory/Pharma/FA% 202006- 001%20Warnin%20on%20the%20use%20of%20 bangkok%20pills.pdf [Accessed 2012 Sep 3]
39. Chua P. Bangkok pills [online]. Available from URL: http://www. thenewstoday.info/2008/01/04/bangkok.pills.html [Accessed 2012 Sep 3]
40. Cheng H, Kotler P, Lee N. Social marketing for public health: an introduction. In: Cheng H, Kotler P, Lee N, editors. Social marketing for public health: global trends and success stories. Jones & Bartlett Publishing, 2011: 1-28
41. Bowdler J, editor. Dialogue in pharmacovigilance. Sweden: Uppsala Monitoring Center, 2002
42. Rifkin E, Bouwer E. The illusion of certainty (health benefits and risks). New York: Springer Science + Business Media, LLC, 2007